Zhong Liu

Bengbu, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Multiomics and Genomic Alteration Characterization Identifies VDAC1 as a Mitochondrial-Associated Biomarker in Pancreatic Cancer.

Multiomics and Genomic Alteration Characterization Identifies VDAC1 as a Mitochondrial-Associated Biomarker in Pancreatic Cancer.

Journal: Human mutation
Published: February 06, 2026

H2AFY regulates autophagy-dependent ferroptosis through ITM2A in hepatocellular carcinoma progression.

H2AFY regulates autophagy-dependent ferroptosis through ITM2A in hepatocellular carcinoma progression.

Journal: Archives of biochemistry and biophysics
Published: December 25, 2025

Machine learning-driven prediction of immune checkpoint inhibitor responses against cholangiocarcinoma: a bile biopsy perspective.

Machine learning-driven prediction of immune checkpoint inhibitor responses against cholangiocarcinoma: a bile biopsy perspective.

Journal: Frontiers in immunology
Published: April 19, 2025

Integrative analysis of bulk and single-cell transcriptomic data reveals novel insights into lipid metabolism and prognostic factors in hepatocellular carcinoma.

Integrative analysis of bulk and single-cell transcriptomic data reveals novel insights into lipid metabolism and prognostic factors in hepatocellular carcinoma.

Journal: Discover oncology
Published: June 21, 2024

USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation.

USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation.

Journal: Cell death & disease
Published: July 30, 2023

Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity.

Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity.

Journal: Frontiers in medicine
Published: June 01, 2023

HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.

HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.

Journal: World journal of surgical oncology
Published: May 16, 2023

LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients.

LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients.

Journal: BMC bioinformatics
Published: November 04, 2022

Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma.

Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma.

Journal: Scientific reports
Published: September 14, 2022

Application of mesohepatectomy with caudate lobectomy for the treatment of type III-IV hilar cholangiocarcinoma: a single-center retrospective study.

Application of mesohepatectomy with caudate lobectomy for the treatment of type III-IV hilar cholangiocarcinoma: a single-center retrospective study.

Journal: European journal of medical research
Published: August 20, 2022

Influencing factors of biliary fistula after radical resection of hilar cholangiocarcinoma: a prospect cohort.

Influencing factors of biliary fistula after radical resection of hilar cholangiocarcinoma: a prospect cohort.

Journal: European journal of medical research
Published: July 14, 2022

Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma.

Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma.

Journal: OncoTargets and therapy
Published: November 10, 2018
Showing 1-12 of 13

Last Updated: 09/26/2026